Background illustration for clinical trials search

Paid Clinical Trials Seattle

Discover 1,464 paid clinical trials in Seattle, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

for
T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Location: Seattle WA, Los Angeles CA, Duarte CA, Denver CO,
Sponsor: Allotera Therapeutics

Sex: All

Age: 0+

Code: NCT06514794

Phase 2, Recruiting

The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program

for
Influenza
Location: Seattle WA, Chicago IL
Sponsor: University of Colorado, Denver

Sex: All

Age: 0 - 70+

Code: NCT05832307

Recruiting

A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis

for
Eosinophilic Esophagitis (EoE)
Location: Seattle WA, San Francisco CA, Aurora CO, Phoenix AZ,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 0 - 6

Code: NCT07112378

Phase 3, Recruiting

Trial of Partial Enteral Nutrition With Dairy Free Diet in Eosinophilic Esophagitis

for
Eosinophilic Esophagitis (EoE)
Location: Seattle WA
Sponsor: Kate Farms Inc

Sex: All

Age: 1 - 21

Code: NCT07234825

Recruiting

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

for
Patients With Non-Small Cell Lung Cancer
Location: Gig Harbor WA, Tacoma WA, Puyallup WA, Beverly Hills CA,
Sponsor: OSE Immunotherapeutics

Sex: All

Age: 18+

Code: NCT06472245

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Childhood Cancer Survivor Study

for
Cancer
Location: Seattle WA, San Francisco CA, Stanford CA,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0+

Code: NCT01120353

Recruiting

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

for
Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG,
Location: Seattle WA, Aurora CO, Houston TX, Ann Arbor MI,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 1 - 39

Code: NCT06838676

Phase 2, Recruiting

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

for
Chronic Myelogenous Leukemia,
Location: Seattle WA, Edmonton, Cincinnati OH, Montreal,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 1 - 18

Code: NCT07354074

Phase 2, Recruiting

Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)

for
Recurrent Atypical Teratoid/Rhabdoid Tumor,
Location: Seattle WA, San Francisco CA
Sponsor: Sabine Mueller, MD, PhD

Sex: All

Age: 1 - 39

Code: NCT07447076

Phase 2, Recruiting

Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials

for
Duchenne Muscular Dystrophy (DMD), Cardiomyopathy,
Location: Seattle WA, Sacramento CA, Chicago IL, Indianapolis IN,
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 0+

Code: NCT07674758

Recruiting

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

for
Desmoplastic Small Round Cell Tumor, Osteosarcoma,
Location: Seattle WA, Portland OR, Palo Alto CA, Los Angeles CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12 - 39

Code: NCT04616560

Phase 2, Recruiting

Optimal Ventilation for Cardiac Arrest

for
Cardiac Arrest (CA)
Location: Seattle WA, Palo Alto CA, Orange CA, Denver CO,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 18

Code: NCT07114510

Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Seattle WA, Tacoma WA, Portland OR, Spokane WA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase 3, Recruiting

Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

for
Charcot-Marie-Tooth Disease, Type Ia (Disorder), HMSN
Location: Seattle WA, Palo Alto CA, Los Angeles CA, Aurora CO,
Sponsor: University of Iowa

Sex: All

Age: 0+

Code: NCT01193088

Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Seattle WA, Tacoma WA, Portland OR, Reno NV, Oakland CA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase 3, Recruiting

A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy

for
Duchene Muscular Dystrophy
Location: Seattle WA, Portland OR, Chicago IL, Little Rock AR,
Sponsor: ITF Therapeutics LLC

Sex: All

Age: 6+

Code: NCT07127978

Recruiting

Non-invasive Prediction of EArly Cardiac rEjection

for
Heart Transplant, Pediatric Heart Transplant, Rejection,
Location: Seattle WA, Palo Alto CA, Los Angeles CA, Denver CO,
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 6 - 25

Code: NCT07770659

Recruiting

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

for
Non-Small Cell Lung Cancer (NSCLC)
Location: Olympia WA, Santa Barbara CA, Albuquerque NM,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT05920356

Phase 3, Recruiting

Minima Stent System Post- Approval Study (PAS)

for
Pulmonary Artery Stenosis, Aortic Coarctation
Location: Seattle WA, Los Angeles CA, Aurora CO, Dallas TX,
Sponsor: Renata Medical

Sex: All

Age: 0+

Code: NCT06828770

Recruiting

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

for
Generalized Myasthenia Gravis
Location: Seattle WA, Chicago IL, Austin TX, Philadelphia PA
Sponsor: Amgen

Sex: All

Age: 2 - 17

Code: NCT06987539

Phase 2, Recruiting

As one of the fastest growing cities in America, Seattle stands out as a pivotal location for clinical research. Home to an extensive healthcare network and prominent research institutions, Seattle offers innovative approaches to clinical research and a significant contribution to medical science.

Leading centers such as the Fred Hutchinson Cancer Research Center, the University of Washington Medical Center, and the Seattle Children's Research Institute are at the forefront of groundbreaking studies.

Article preview image

Want a closer look at research in Seattle? Read our guide: Clinical Trials in Seattle: Where to Find Studies Near You

Inside Seattle's Clinical Trial Ecosystem: the Region's Research Hub

Why choose Seattle for clinical trials?

For those considering participating in a clinical trial, there are several reasons why Seattle is a prime choice. The city is home to a robust network of leading research institutions, which are known for their pioneering work and advanced medical research. Seattle’s collaborative environment and emphasis on innovation enhance the quality and impact of clinical studies.

By participating in a clinical trial in Seattle, you gain access to some of the most advanced research and treatments available, while also contributing to significant medical discoveries. The city's commitment to cutting-edge science and a supportive research infrastructure make it an ideal location for advancing medical knowledge and improving future healthcare outcomes.

Common conditions studied in Seattle

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Seattle